Literature DB >> 17018882

In vitro interaction between homocysteine and copper ions: Potential redox implications.

Catalina Carrasco-Pozo1, Alejandro Alvarez-Lueje, Claudio Olea-Azar, Camilo López-Alarcón, Hernán Speisky.   

Abstract

Homocysteine (Hcys) has been implicated in various oxidative stress-related disorders. The presence of a thiol on its structure allows Hcys to exert a double-edge redox action. Depending on whether Cu2+ ions occur concomitantly, Hcys can either promote or prevent free radical generation and its consequences. We have addressed in vitro the interaction between Hcys and Cu2+ ions, in terms of the consequences that such interaction may have on the free radical scavenging properties of Hcys and on the redox state and redox activity of the metal. To this end, we investigated the free radical-scavenging, O2(*-)-generating, and ascorbate-oxidizing properties of the interacting species by assessing the bleaching of ABTS*+ radicals, the reduction of O2(*-)-dependent cytochrome c, and the copper-dependent oxidation of ascorbate, respectively. In addition, electron paramagnetic resonance and Cu(I)-bathocuproine formation were applied to assess the formation of paramagnetic complexes and the metal redox state. Upon a brief incubation, the Hcys/Cu2+ interaction led to a decrease in the free radical-scavenging properties of Hcys, and to a comparable loss of the thiol density. Both effects were partial and were not modified by increasing the incubation time, despite the presence of Cu2+ excess. Depending on the molar Hcys:Cu2+ ratio, the interaction resulted in the formation of mixtures that appear to contain time-stable and ascorbate-reducible Cu(II) complexes (for ratios up to 2:1), and ascorbate- and oxygen-redox-inactive Cu(I) complexes (for ratios up to 4:1). Increasing the interaction ratio beyond 4:1 was associated with the sudden appearance of an O2(*-)-generating activity. The data indicate that depending on the molar ratio of interaction, Hcys and Cu2+ react to form copper complexes that can promote either antioxidant or pro-oxidant actions. We speculate that the redox activity arising from a large molar Hcys excess may partially underlie the association between hyper-homocysteinemia and a greater risk of developing oxidative-related cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018882     DOI: 10.1177/153537020623100918

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  6 in total

1.  Melanosomal damage in normal human melanocytes induced by UVB and metal uptake--a basis for the pro-oxidant state of melanoma.

Authors:  Shirley Gidanian; Mallory Mentelle; Frank L Meyskens; Patrick J Farmer
Journal:  Photochem Photobiol       Date:  2008-03-07       Impact factor: 3.421

2.  Plasma oxidized LDL and thiol-containing molecules in patients with exudative age-related macular degeneration.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Elham Bahreini; Nadereh Rashtchizadeh; Hassan Argani; Samira Alizadeh
Journal:  Mol Vis       Date:  2010-12-06       Impact factor: 2.367

3.  Disturbance of copper homeostasis is a mechanism for homocysteine-induced vascular endothelial cell injury.

Authors:  Daoyin Dong; Biao Wang; Wen Yin; Xueqing Ding; Jingjing Yu; Y James Kang
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

Review 4.  Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications.

Authors:  Grażyna Gromadzka; Beata Tarnacka; Anna Flaga; Agata Adamczyk
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

5.  Lysosome-Targeting Fluorescence Sensor for Sequential Detection and Imaging of Cu2+ and Homocysteine in Living Cells.

Authors:  Lihua Liu; Hongfei Duan; Haohui Wang; Jieru Miao; Zhihui Wu; Chenxi Li; Yan Lu
Journal:  ACS Omega       Date:  2022-09-14

6.  Homocysteine restricts copper availability leading to suppression of cytochrome C oxidase activity in phenylephrine-treated cardiomyocytes.

Authors:  Xiao Zuo; Daoyin Dong; Miao Sun; Huiqi Xie; Y James Kang
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.